Testing biocompatibility during the designing process is important, but biocompatible for the device has to be managed across its entire lifecycle. If a new method is used when making a product, like ...

@krish I definitely agree with you that organ on a chip model are slowly reducing our dependence on animal studies. The FDA themselves have also pushed for this, as the FDA Modernization Act 2.0 allow...

I have just started working in the biopharmaceutical industry, and one of the things they really hammer down is following protocol in order to stay within federal regulations. If we slip out of compli...

It's fine to consider some innovation, as long you can differentiate something the project truly needs and is worth the potential extra time and resources to enact this change. In my experience workin...

I agree with having feasibility check at the initiation phase of the project. However, to add to that, maybe it would be good practice to hold a risk assessment meeting and come up with a certain cond...

Depending on the severity of the disagreement, it can be helpful to the team if you also bring an outside perspective, specifically someone who has faced an issue similar to the one causing the disagr...

I actually see the jack of all trades aspect of BME having some positive outcomes in my own experience. For me specifically, I wanted to focus on data analysis focus jobs, but because I also had exper...

I'd lean more toward more co-ops or longer internships, due to the multiple years of experience employer often expect for a lot of jobs. For students, co-op can give the student the required experienc...

I also see myself drawn to industry. For me, it's mostly because I feel more comfortable dealing with a defined problem with a set deadline rather than the more open-ended approach. I've noticed that ...

To make the team aware of risk on even smaller, simpler projects, you could incorporate short "Risk Sprints" in regular intervals of the planning cycle. In each of these meetings, the team will look f...

One way of convincing management to invest in more contingency planning is to remind them that it is a regulatory and compliance risk. If the primary supplier cannot meet quality standards post its ap...

For long-running clinical trials, there are many ways to maintain engagement and motivation among team members. One way is to celebrate small milestones, like completing a trial phase. Showing appreci...

One obstacle that can complicate timeline planning for large scale clinical trials is the variability added by conducting trials across multiple countries. Global trials come with more complexity that...

The first step should be to identify why the underperformance is happening, which can lead to visits to monitor process or talking to the team themselves to find the root cause. Then the necessary cha...

One strategy that can be used for keeping clinical research teams motivated is to create and celebrate short-term wins. It was mentioned in this week's slides that one motivator for people is team bas...